Literature DB >> 27931842

Quality end-of-Life cancer care: An overdue imperative.

Guy B Faguet1.   

Abstract

This review assesses the current status of end-of-life care based on large-scale, multiyear nationwide surveys of treatment modality, setting, and cost of care during terminal patients' last months of life. It shows that end-of-life care goals often remain suboptimal. Contributing factors include prioritized life preservation, uneven commitment to palliative care, few palliative care specialists, and perverse financial incentives that encourage costly interventions. Although not determinant per se, these factors coupled to doubts about what constitutes end-of-life can lead to overextended disease treatment and a late implementation of palliative care. In order to bridge the existing gap between care received and care expected and achieve quality end-of-life and promote death with dignity, we propose both to view the person rather than the disease as the unit of care and a pragmatic definition of end-of-life. Such a strategy should facilitate selecting an optimal time to transition from disease-targeted treatment to palliative care. Copyright Â
© 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Cancer; Dying with dignity; End-of-life; Palliative care; Quality of life

Mesh:

Year:  2016        PMID: 27931842     DOI: 10.1016/j.critrevonc.2016.10.012

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN: 1040-8428            Impact factor:   6.312


  4 in total

1.  Factors associated with palliative care referral among patients with advanced cancers: a retrospective analysis of a large Brazilian cohort.

Authors:  Talita Caroline de Oliveira Valentino; Bianca Sakamoto Ribeiro Paiva; Marco Antonio de Oliveira; David Hui; Carlos Eduardo Paiva
Journal:  Support Care Cancer       Date:  2018-01-05       Impact factor: 3.603

2.  Research progress of the transcription factor Brn4 (Review).

Authors:  Yuying Wu; Xunrui Zhang; Jue Wang; Guohua Jin; Xinhua Zhang
Journal:  Mol Med Rep       Date:  2021-01-05       Impact factor: 2.952

3.  Patients' quality of life during active cancer treatment: a qualitative study.

Authors:  Jordan Sibeoni; Camille Picard; Massimiliano Orri; Mathilde Labey; Guilhem Bousquet; Laurence Verneuil; Anne Revah-Levy
Journal:  BMC Cancer       Date:  2018-10-04       Impact factor: 4.430

4.  Personality matters: relationship between personality characteristics, spirituality, demoralization, and perceived quality of life in a sample of end-of-life cancer patients.

Authors:  Ada Ghiggia; Vanni Pierotti; Valentina Tesio; Andrea Bovero
Journal:  Support Care Cancer       Date:  2021-06-24       Impact factor: 3.603

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.